Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Aurobindo Pharma Ltd is up for a third straight session today. The stock is quoting at Rs 1097, up 4.45% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.1% on the day, quoting at 24997.1. The Sensex is at 81530.73, up 0.13%. Aurobindo Pharma Ltd has gained around 3.67% in last one month.
Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has gained around 2.11% in last one month and is currently quoting at 22122.05, up 0.41% on the day. The volume in the stock stood at 32.48 lakh shares today, compared to the daily average of 13 lakh shares in last one month.
The benchmark September futures contract for the stock is quoting at Rs 1100.1, up 4.22% on the day. Aurobindo Pharma Ltd is down 29.74% in last one year as compared to a 1.54% slide in NIFTY and a 5.19% slide in the Nifty Pharma index.
The PE of the stock is 31.13 based on TTM earnings ending June 25.
The company clarified that the observations are procedural in nature and do not affect its financials or operations. Aurobindo added that it will submit a detailed response to the USFDA within the stipulated timelines.
“The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe,” it said.
Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.
The company’s consolidated net profit tumbled 10.3% to Rs 824.75 crore despite a 4.5% increase in revenue from operations to Rs 7791.77 crore in Q1 FY26 over Q1 FY25.
Shares of Aurobindo Pharma rose 0.23% to Rs 1,046.85 on the BSE.